Nutrition and Public Health Research Group, Nutrition Institute, Ljubljana, Slovenia.
VIST - Higher School of Applied Sciences, Ljubljana, Slovenia.
Compr Rev Food Sci Food Saf. 2021 Mar;20(2):1307-1332. doi: 10.1111/1541-4337.12716. Epub 2021 Feb 10.
Nutrition is recognized as one of the leading factors influencing the growing incidence of noncommunicable diseases. Despite society experiencing a global rise in obesity, specific populations remain at risk of nutrient deficiencies. The food industry can use health claims to inform consumers about the health benefits of foods through labeling and the broader promotion of specific food products. As health claims are carefully regulated in many countries, their use is limited due to considerable investments required to fulfill the regulatory requirement. Although health claims represent a driving force for innovation in the food industry, the risk of misleading of consumers need to be avoided. The health claim scientific substantiation process must be efficient and transparent in order to meet the needs of companies in the global market, but should be based on strong scientific evidence and plausible mechanisms of actions, to ensure highest level of consumer protection. The objective of this review is to compare the possibilities for using health claims on foods in the European Union, the USA, Canada, and Australia and New Zealand. In particular, we focused on differences in the classification of claims, on the scientific substantiation processes and requirements for health claims use on foods in the selected regions. Reduction of disease risk (RDR) claims are associated with relatively similar procedures and conditions for use, whereas several notable differences were identified for other types of claims. In all cases, RDR claims must be approved prior their introduction to the market, and only a few such claims have been authorized. Much greater differences were observed concerning other types of claims.
营养被认为是影响非传染性疾病发病率不断上升的主要因素之一。尽管社会普遍存在肥胖问题,但某些人群仍然存在营养缺乏的风险。食品行业可以通过标签和更广泛地推广特定食品来利用健康声明向消费者宣传食品的健康益处。由于许多国家对健康声明进行了严格监管,由于需要大量投资来满足监管要求,其使用受到限制。尽管健康声明代表了食品行业创新的驱动力,但需要避免对消费者产生误导的风险。健康声明的科学依据过程必须高效透明,以满足全球市场中公司的需求,但应基于强有力的科学证据和合理的作用机制,以确保消费者得到最高水平的保护。本综述的目的是比较欧盟、美国、加拿大和澳大利亚及新西兰在食品上使用健康声明的可能性。特别是,我们专注于分类声明、科学依据程序以及在选定地区食品上使用健康声明的要求方面的差异。降低疾病风险(RDR)声明与使用的相对类似的程序和条件相关联,而对于其他类型的声明则发现了一些明显的差异。在所有情况下,RDR 声明必须在引入市场之前获得批准,并且只有少数此类声明获得批准。对于其他类型的声明,观察到了更大的差异。